Cargando…
Delirium in COVID-19: psychopharmacology considerations
INTRODUCTION: Delirium is characterized by fluctuating disturbance of consciousness, inattention, reduced awareness, hallucinations or delusions, occurring in 20% of hospital admissions. Central nervous system symptoms are the main form of neurologic injury in patients with COVID-19 and a significan...
Autores principales: | Lemos, M., Rema, J., De Sousa, T. Reynolds |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528405/ http://dx.doi.org/10.1192/j.eurpsy.2021.734 |
Ejemplares similares
-
The challenges of psychopharmacological treatment during the COVID-19 pandemic in lombardy
por: Vita, A.
Publicado: (2021) -
Psychopharmacology of COVID-19
por: Bilbul, Melanie, et al.
Publicado: (2020) -
Psychopharmacological treatment in dissociative identity disorder (DID)
por: Pinilla, R., et al.
Publicado: (2021) -
Psychopharmacology In Myasthenia Gravis Patients: A Case Study
por: Afonso, T. M., et al.
Publicado: (2023) -
Psychocardiology in a heartbeat: cardiac complications to consider in psychopharmacology
por: Conde Moreno, M., et al.
Publicado: (2022)